Search
Certara Inc
CERTAdd to Watchlist
4.480USD
-0.130-2.82%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
686.90MMarket Cap
LossP/E TTM
More Details of Certara Inc Company
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.
Certara Inc Info
Ticker SymbolCERT
Company nameCertara Inc
IPO dateDec 11, 2020
CEOFeehery (William F)
Number of employees1487
Security typeOrdinary Share
Fiscal year-endDec 11
Address4 Radnor Corporate Center, Suite 350
CityRADNOR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19087
Phone14152378272
Websitehttps://www.certara.com/
Ticker SymbolCERT
IPO dateDec 11, 2020
CEOFeehery (William F)
Company Executives of Certara Inc
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
95.37K
+51.21%
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
--
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
--
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
11.88K
+56.40%
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. James E. Cashman, III
Mr. James E. Cashman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Matthew Walsh
Mr. Matthew Walsh
Independent Director
Independent Director
--
--
Mr. Stephen M. Mclean
Mr. Stephen M. Mclean
Independent Director
Independent Director
--
--
Dr. Robert P. Aspbury, Ph.D.
Dr. Robert P. Aspbury, Ph.D.
President - Certara Predictive Technologies
President - Certara Predictive Technologies
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. John E. Gallagher, III
Mr. John E. Gallagher, III
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
95.37K
+51.21%
Ms. Nancy Killefer
Ms. Nancy Killefer
Independent Director
Independent Director
36.09K
--
Mr. Eran Broshy
Mr. Eran Broshy
Independent Director
Independent Director
34.95K
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
29.91K
--
Ms. Rona Anhalt
Ms. Rona Anhalt
Chief Human Resources Officer
Chief Human Resources Officer
11.88K
+56.40%
Dr. William F. (Bill) Feehery, Ph.D.
Dr. William F. (Bill) Feehery, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
Americas
291.60M
69.62%
EMEA
92.63M
22.12%
Asia Pac
34.61M
8.26%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
23.36%
BlackRock Institutional Trust Company, N.A.
8.34%
Dimensional Fund Advisors, L.P.
5.50%
Deerfield Management Company, L.P.
5.02%
Jefferies LLC
4.41%
Other
53.36%
Shareholders
Shareholders
Proportion
Arsenal Capital Management LP
23.36%
BlackRock Institutional Trust Company, N.A.
8.34%
Dimensional Fund Advisors, L.P.
5.50%
Deerfield Management Company, L.P.
5.02%
Jefferies LLC
4.41%
Other
53.36%
Shareholder Types
Shareholders
Proportion
Investment Advisor
35.83%
Investment Advisor/Hedge Fund
29.62%
Private Equity
23.71%
Hedge Fund
11.94%
Research Firm
7.70%
Pension Fund
3.34%
Bank and Trust
3.33%
Individual Investor
2.50%
Venture Capital
0.07%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
590
177.30M
115.63%
-46.00M
2025Q4
558
185.12M
131.81%
+1.00M
2025Q3
573
184.07M
131.10%
+12.68M
2025Q2
560
171.32M
126.85%
+5.75M
2025Q1
564
165.12M
122.63%
-32.91M
2024Q4
543
158.45M
114.11%
+1.19M
2024Q3
537
155.91M
127.98%
-4.99M
2024Q2
523
160.73M
126.95%
+18.44K
2024Q1
516
160.66M
125.87%
-40.98M
2023Q4
507
159.05M
107.80%
-1.16M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Arsenal Capital Management LP
36.35M
22.84%
--
--
Apr 14, 2025
BlackRock Institutional Trust Company, N.A.
12.98M
8.16%
+95.30K
+0.74%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
8.39M
5.27%
+35.20K
+0.42%
Dec 31, 2025
Deerfield Management Company, L.P.
7.81M
4.91%
--
--
Dec 31, 2025
Jefferies LLC
3.03M
1.9%
+3.03M
--
Dec 31, 2025
ArrowMark Colorado Holdings, LLC
5.49M
3.45%
-1.89M
-25.65%
Dec 31, 2025
Wasatch Global Investors Inc
17.22M
10.82%
-175.26K
-1.01%
Dec 31, 2025
State Street Investment Management (US)
3.92M
2.46%
+83.70K
+2.18%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
0.86%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.39%
First Trust Active Factor Small Cap ETF
0.22%
iShares U.S. Healthcare Providers ETF
0.22%
First Trust Small Cap Growth AlphaDEX Fund
0.22%
State Street SPDR S&P 600 Small Cap Value ETF
0.2%
Harbor Human Capital Factor US Small Cap ETF
0.19%
iShares S&P Small-Cap 600 Value ETF
0.15%
State Street SPDR S&P SmallCap 600 ESG ETF
0.14%
First Trust Small Cap Core Alphadex Fund
0.12%
View more
Invesco S&P SmallCap Health Care ETF
Proportion0.86%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.39%
First Trust Active Factor Small Cap ETF
Proportion0.22%
iShares U.S. Healthcare Providers ETF
Proportion0.22%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.22%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.2%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.19%
iShares S&P Small-Cap 600 Value ETF
Proportion0.15%
State Street SPDR S&P SmallCap 600 ESG ETF
Proportion0.14%
First Trust Small Cap Core Alphadex Fund
Proportion0.12%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
